Skip to main content


Patients with MGUS are at risk to develop lymphoproliferative diseases such as myeloma or malignant lymphoma. They should be re-examined annually and at those times the following tests should be obtained:

  • CBC, serum creatinine, calcium
  • Serum and 24 h urine protein electrophoreses
  • Skeletal survey (optional after 3-5 years of observation with no evidence of progression)​​​​
SOURCE: Follow-up ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer. All Rights Reserved.

    Copyright © 2021 Provincial Health Services Authority